SIOG – International Society of Geriatric Oncology shared on LinkedIn:
“Only around 20% of older adults are included in the clinical trials that generate the evidence guiding their care.
Over the age of 75, that figure drops to 10% or less.
SIOG 2026 addresses this directly.
The clinical trials plenary examines how drug development came to exclude older adults and what more rigorous, inclusive study design looks like in practice.
The Methods session looks at how implementation science can close the gap between what the evidence says and what actually happens in clinic.
If your work involves generating or applying evidence in geriatric oncology, this is the programme your peers are building around.
Early bird rates are open until 8 September.”
To which Sandi Vonnes, Geriatric Expert at Change AGEnt LLC, added:
“See you in Valencia?”
Other articles about SIOG on OncoDaily.